----item----
version: 1
id: {60B4FA3F-7409-47FE-88C2-6CB13FF7CE81}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/10/21/All Change For BIA Board
parent: {99A8E8E0-2038-4AC6-A370-61351CFAC90A}
name: All Change For BIA Board
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 6236e079-0f6b-4cd6-8b80-d32b2e49a67e

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 24

All Change For BIA Board
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 24

All Change For BIA Board
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1266

<p>The UK BioIndustry Association (BIA) has named Dr. Jane Osbourn &ndash; current vice-president of research and development at MedImmune LLC (an AstraZeneca plc company) &ndash; its new chair, effective January 2016. Osbourn has over 25 years of experience in the life science sector, initially as an academic before moving into biotech with Cambridge Antibody Technology in 1993. Osbourn received her Ph.D. from the John Innes Centre for Plant Science Research in Norwich. She succeeds Dr. Edward Hodgkin, CEO of Autolus, who is standing down as chair of the board but will remain a director.</p><p>Osbourn's appointment was made at the BIA annual general meeting on Oct. 15. At this meeting four new board members were elected and one member re-elected to serve from January 2016 for a term of three years. The new members are: Dr. Darrin Disley, CEO of Horizon Discovery Group; David Hipkiss, chief business officer at Circassia Pharmaceuticals; Peptinnovate CEO Dr. Andrew Lightfoot; and Redx Pharma CEO Dr. Neil Murray. Dr. Celia Caulcott, vice-provost (enterprise) at UCL Business, was re-elected. </p><p>Dr. Harren Jhoti, president and CEO of Astex Pharmaceuticals and Patrick Verheyen, head of Johnson & Johnson Innovation, have resigned as directors. </p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 599

<p>The UK BioIndustry Association (BIA) has named Dr. Jane Osbourn &ndash; current vice-president of research and development at MedImmune LLC (an AstraZeneca plc company) &ndash; its new chair, effective January 2016. Osbourn has over 25 years of experience in the life science sector, initially as an academic before moving into biotech with Cambridge Antibody Technology in 1993. Osbourn received her Ph.D. from the John Innes Centre for Plant Science Research in Norwich. She succeeds Dr. Edward Hodgkin, CEO of Autolus, who is standing down as chair of the board but will remain a director.</p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 24

All Change For BIA Board
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20151021T230007
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20151021T230007
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20151021T230007
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC030113
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 24

All Change For BIA Board
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{090E9A04-9B4B-4986-8BAF-06A6B07B978D}
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

361071
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042509Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

6236e079-0f6b-4cd6-8b80-d32b2e49a67e
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042509Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
